
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $3.6B | -- | -- | $0.83 | -- |
08/07/2025 | Q2 | $3.1B | -- | -- | $0.70 | -- |
05/06/2025 | Q1 | $2.7B | $2.6B | $0.75 | $0.45 | $0.30 |
02/27/2025 | Q4 | $2.9B | $2.8B | $0.53 | $0.57 | -$0.04 |
11/12/2024 | Q3 | $3.1B | $2.8B | $0.38 | $0.52 | -$0.14 |
08/06/2024 | Q2 | $3B | $2.8B | -$0.50 | $0.66 | -$1.16 |
05/01/2024 | Q1 | $2.8B | $2.7B | $0.14 | $0.66 | -$0.52 |
02/21/2024 | Q4 | $3.1B | $3.1B | $1.11 | $0.86 | $0.25 |
11/07/2023 | Q3 | -- | -- | -$0.01 | $0.75 | -$0.76 |
08/01/2023 | Q2 | -- | -- | $1.11 | $1.10 | $0.01 |
05/03/2023 | Q1 | -- | -- | $1.28 | $1.25 | $0.03 |
02/22/2023 | Q4 | -- | -- | $1.52 | $2.20 | -$0.68 |
11/07/2022 | Q3 | -- | -- | $2.42 | $3.40 | -$0.98 |
08/01/2022 | Q2 | -- | -- | $2.85 | -- | -- |
05/02/2022 | Q1 | -- | -- | $3.19 | -- | -- |
02/23/2022 | Q4 | -- | -- | $1.76 | -- | -- |
11/01/2021 | Q3 | -- | -- | $0.97 | -- | -- |
08/02/2021 | Q2 | -- | -- | $1.14 | -- | -- |
05/03/2021 | Q1 | -- | -- | $0.41 | -- | -- |
02/17/2021 | Q4 | -- | -- | $2.17 | -- | -- |
11/02/2020 | Q3 | -- | -- | -$0.02 | -- | -- |
08/03/2020 | Q2 | -- | -- | $0.12 | -- | -- |
05/04/2020 | Q1 | -- | -- | -$0.54 | -- | -- |
02/19/2020 | Q4 | -- | -- | -$2.43 | -- | -- |
11/04/2019 | Q3 | -- | -- | -$0.11 | -- | -- |
08/05/2019 | Q2 | -- | -- | -$0.60 | -- | -- |
05/06/2019 | Q1 | -- | -- | $0.34 | -- | -- |
02/25/2019 | Q4 | -- | -- | $0.29 | -- | -- |
11/06/2018 | Q3 | -- | -- | $0.64 | -- | -- |
08/07/2018 | Q2 | -- | -- | $0.18 | -- | -- |
05/08/2018 | Q1 | -- | -- | $0.11 | -- | -- |
02/20/2018 | Q4 | -- | -- | -$1.23 | -- | -- |
11/07/2017 | Q3 | -- | -- | $0.65 | -- | -- |
08/01/2017 | Q2 | -- | -- | $0.28 | -- | -- |
05/02/2017 | Q1 | -- | -- | -$0.00 | -- | -- |
02/07/2017 | Q4 | -- | -- | $0.03 | -- | -- |
11/01/2016 | Q3 | -- | -- | $0.11 | -- | -- |
08/02/2016 | Q2 | -- | -- | -$0.03 | -- | -- |
05/04/2016 | Q1 | -- | -- | $0.73 | -- | -- |
02/11/2016 | Q4 | -- | -- | $0.44 | -- | -- |
11/03/2015 | Q3 | -- | -- | $0.45 | -- | -- |
The Mosaic reported $2.6B worth of top line sales in its most recent quarter.
The Mosaic announced earnings per share of $0.75 which represents a beat of analyst forecast a $0.45 per share.
The Mosaic reported $488.4M that represents $1.53 per share over the last quarter.
The Mosaic's earnings are forecast to grow from $0.55 per share to $2.14 per share next year representing an increase of 428.01%.
The Mosaic's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.